0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global γ-Aminobutyric Acid Receptor Agonists Market Research Report 2025
Published Date: February 2025
|
Report Code: QYRE-Auto-33J18938
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global γ Aminobutyric Acid Receptor Agonists Market Research Report 2025
BUY CHAPTERS

Global γ-Aminobutyric Acid Receptor Agonists Market Research Report 2025

Code: QYRE-Auto-33J18938
Report
February 2025
Pages:119
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

γ-Aminobutyric Acid Receptor Agonists Market Size

The global market for γ-Aminobutyric Acid Receptor Agonists was valued at US$ 2069 million in the year 2024 and is projected to reach a revised size of US$ 4393 million by 2031, growing at a CAGR of 11.5% during the forecast period.

γ-Aminobutyric Acid Receptor Agonists Market

γ-Aminobutyric Acid Receptor Agonists Market

γ-Aminobutyric acid receptor agonists are compounds that bind to and activate γ-aminobutyric acid (GABA) receptors. By enhancing the inhibitory effects of GABA receptors, they promote inhibitory neurotransmission in the nervous system, typically exhibiting pharmacological effects such as sedation, anxiolysis, and anticonvulsant properties.
North American market for γ-Aminobutyric Acid Receptor Agonists is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for γ-Aminobutyric Acid Receptor Agonists is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of γ-Aminobutyric Acid Receptor Agonists include Pfizer, Teva, Torrent Pharma, Roche, Akorn, Apotex, Fresenius Kabi, Hikma, Mylan, Sandoz, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for γ-Aminobutyric Acid Receptor Agonists, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding γ-Aminobutyric Acid Receptor Agonists.
The γ-Aminobutyric Acid Receptor Agonists market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global γ-Aminobutyric Acid Receptor Agonists market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the γ-Aminobutyric Acid Receptor Agonists manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of γ-Aminobutyric Acid Receptor Agonists Market Report

Report Metric Details
Report Name γ-Aminobutyric Acid Receptor Agonists Market
Accounted market size in year US$ 2069 million
Forecasted market size in 2031 US$ 4393 million
CAGR 11.5%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
Segment by Application
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Pfizer, Teva, Torrent Pharma, Roche, Akorn, Apotex, Fresenius Kabi, Hikma, Mylan, Sandoz, Sun Pharma, WG Critical Care, Takeda, Shanghai Pharmaceuticals Holding, CHEPLAPHARM, Neurelis, Huazhong Pharmaceutical, Changzhou Siyao Pharmaceutical, SAGE Therapeutics, GSK, Sanofi, Sichuan HaiscoPharmaceuical, Novartis, AstraZeneca, Viatris, Jazz Pharmaceuicals
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of γ-Aminobutyric Acid Receptor Agonists manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of γ-Aminobutyric Acid Receptor Agonists in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

How fast is γ-Aminobutyric Acid Receptor Agonists Market growing?

Ans: The γ-Aminobutyric Acid Receptor Agonists Market witnessing a CAGR of 11.5% during the forecast period 2025-2031.

What is the γ-Aminobutyric Acid Receptor Agonists Market size in 2031?

Ans: The γ-Aminobutyric Acid Receptor Agonists Market size in 2031 will be US$ 4393 million.

Who are the main players in the γ-Aminobutyric Acid Receptor Agonists Market report?

Ans: The main players in the γ-Aminobutyric Acid Receptor Agonists Market are Pfizer, Teva, Torrent Pharma, Roche, Akorn, Apotex, Fresenius Kabi, Hikma, Mylan, Sandoz, Sun Pharma, WG Critical Care, Takeda, Shanghai Pharmaceuticals Holding, CHEPLAPHARM, Neurelis, Huazhong Pharmaceutical, Changzhou Siyao Pharmaceutical, SAGE Therapeutics, GSK, Sanofi, Sichuan HaiscoPharmaceuical, Novartis, AstraZeneca, Viatris, Jazz Pharmaceuicals

What are the Application segmentation covered in the γ-Aminobutyric Acid Receptor Agonists Market report?

Ans: The Applications covered in the γ-Aminobutyric Acid Receptor Agonists Market report are Epilepsy, Insomnia, Anxiety, Neuropathic Pain, Other

What are the Type segmentation covered in the γ-Aminobutyric Acid Receptor Agonists Market report?

Ans: The Types covered in the γ-Aminobutyric Acid Receptor Agonists Market report are GABAA Receptors, GABAB Receptors, GABAC Receptors

Recommended Reports

Receptor Agonists Markets

Epilepsy and Anticonvulsants

Neurotransmitters & Related

1 γ-Aminobutyric Acid Receptor Agonists Market Overview
1.1 Product Definition
1.2 γ-Aminobutyric Acid Receptor Agonists by Type
1.2.1 Global γ-Aminobutyric Acid Receptor Agonists Market Value Comparison by Type (2024 VS 2031)
1.2.2 GABAA Receptors
1.2.3 GABAB Receptors
1.2.4 GABAC Receptors
1.3 γ-Aminobutyric Acid Receptor Agonists by Application
1.3.1 Global γ-Aminobutyric Acid Receptor Agonists Market Value by Application (2024 VS 2031)
1.3.2 Epilepsy
1.3.3 Insomnia
1.3.4 Anxiety
1.3.5 Neuropathic Pain
1.3.6 Other
1.4 Global γ-Aminobutyric Acid Receptor Agonists Market Size Estimates and Forecasts
1.4.1 Global γ-Aminobutyric Acid Receptor Agonists Revenue 2020-2031
1.4.2 Global γ-Aminobutyric Acid Receptor Agonists Sales 2020-2031
1.4.3 Global γ-Aminobutyric Acid Receptor Agonists Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 γ-Aminobutyric Acid Receptor Agonists Market Competition by Manufacturers
2.1 Global γ-Aminobutyric Acid Receptor Agonists Sales Market Share by Manufacturers (2020-2025)
2.2 Global γ-Aminobutyric Acid Receptor Agonists Revenue Market Share by Manufacturers (2020-2025)
2.3 Global γ-Aminobutyric Acid Receptor Agonists Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of γ-Aminobutyric Acid Receptor Agonists, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of γ-Aminobutyric Acid Receptor Agonists, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of γ-Aminobutyric Acid Receptor Agonists, Product Type & Application
2.7 Global Key Manufacturers of γ-Aminobutyric Acid Receptor Agonists, Date of Enter into This Industry
2.8 Global γ-Aminobutyric Acid Receptor Agonists Market Competitive Situation and Trends
2.8.1 Global γ-Aminobutyric Acid Receptor Agonists Market Concentration Rate
2.8.2 The Global 5 and 10 Largest γ-Aminobutyric Acid Receptor Agonists Players Market Share by Revenue
2.8.3 Global γ-Aminobutyric Acid Receptor Agonists Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global γ-Aminobutyric Acid Receptor Agonists Market Scenario by Region
3.1 Global γ-Aminobutyric Acid Receptor Agonists Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global γ-Aminobutyric Acid Receptor Agonists Sales by Region: 2020-2031
3.2.1 Global γ-Aminobutyric Acid Receptor Agonists Sales by Region: 2020-2025
3.2.2 Global γ-Aminobutyric Acid Receptor Agonists Sales by Region: 2026-2031
3.3 Global γ-Aminobutyric Acid Receptor Agonists Revenue by Region: 2020-2031
3.3.1 Global γ-Aminobutyric Acid Receptor Agonists Revenue by Region: 2020-2025
3.3.2 Global γ-Aminobutyric Acid Receptor Agonists Revenue by Region: 2026-2031
3.4 North America γ-Aminobutyric Acid Receptor Agonists Market Facts & Figures by Country
3.4.1 North America γ-Aminobutyric Acid Receptor Agonists Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America γ-Aminobutyric Acid Receptor Agonists Sales by Country (2020-2031)
3.4.3 North America γ-Aminobutyric Acid Receptor Agonists Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe γ-Aminobutyric Acid Receptor Agonists Market Facts & Figures by Country
3.5.1 Europe γ-Aminobutyric Acid Receptor Agonists Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe γ-Aminobutyric Acid Receptor Agonists Sales by Country (2020-2031)
3.5.3 Europe γ-Aminobutyric Acid Receptor Agonists Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific γ-Aminobutyric Acid Receptor Agonists Market Facts & Figures by Region
3.6.1 Asia Pacific γ-Aminobutyric Acid Receptor Agonists Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific γ-Aminobutyric Acid Receptor Agonists Sales by Region (2020-2031)
3.6.3 Asia Pacific γ-Aminobutyric Acid Receptor Agonists Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America γ-Aminobutyric Acid Receptor Agonists Market Facts & Figures by Country
3.7.1 Latin America γ-Aminobutyric Acid Receptor Agonists Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America γ-Aminobutyric Acid Receptor Agonists Sales by Country (2020-2031)
3.7.3 Latin America γ-Aminobutyric Acid Receptor Agonists Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa γ-Aminobutyric Acid Receptor Agonists Market Facts & Figures by Country
3.8.1 Middle East and Africa γ-Aminobutyric Acid Receptor Agonists Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa γ-Aminobutyric Acid Receptor Agonists Sales by Country (2020-2031)
3.8.3 Middle East and Africa γ-Aminobutyric Acid Receptor Agonists Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global γ-Aminobutyric Acid Receptor Agonists Sales by Type (2020-2031)
4.1.1 Global γ-Aminobutyric Acid Receptor Agonists Sales by Type (2020-2025)
4.1.2 Global γ-Aminobutyric Acid Receptor Agonists Sales by Type (2026-2031)
4.1.3 Global γ-Aminobutyric Acid Receptor Agonists Sales Market Share by Type (2020-2031)
4.2 Global γ-Aminobutyric Acid Receptor Agonists Revenue by Type (2020-2031)
4.2.1 Global γ-Aminobutyric Acid Receptor Agonists Revenue by Type (2020-2025)
4.2.2 Global γ-Aminobutyric Acid Receptor Agonists Revenue by Type (2026-2031)
4.2.3 Global γ-Aminobutyric Acid Receptor Agonists Revenue Market Share by Type (2020-2031)
4.3 Global γ-Aminobutyric Acid Receptor Agonists Price by Type (2020-2031)
5 Segment by Application
5.1 Global γ-Aminobutyric Acid Receptor Agonists Sales by Application (2020-2031)
5.1.1 Global γ-Aminobutyric Acid Receptor Agonists Sales by Application (2020-2025)
5.1.2 Global γ-Aminobutyric Acid Receptor Agonists Sales by Application (2026-2031)
5.1.3 Global γ-Aminobutyric Acid Receptor Agonists Sales Market Share by Application (2020-2031)
5.2 Global γ-Aminobutyric Acid Receptor Agonists Revenue by Application (2020-2031)
5.2.1 Global γ-Aminobutyric Acid Receptor Agonists Revenue by Application (2020-2025)
5.2.2 Global γ-Aminobutyric Acid Receptor Agonists Revenue by Application (2026-2031)
5.2.3 Global γ-Aminobutyric Acid Receptor Agonists Revenue Market Share by Application (2020-2031)
5.3 Global γ-Aminobutyric Acid Receptor Agonists Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Pfizer
6.1.1 Pfizer Company Information
6.1.2 Pfizer Description and Business Overview
6.1.3 Pfizer γ-Aminobutyric Acid Receptor Agonists Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Pfizer γ-Aminobutyric Acid Receptor Agonists Product Portfolio
6.1.5 Pfizer Recent Developments/Updates
6.2 Teva
6.2.1 Teva Company Information
6.2.2 Teva Description and Business Overview
6.2.3 Teva γ-Aminobutyric Acid Receptor Agonists Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Teva γ-Aminobutyric Acid Receptor Agonists Product Portfolio
6.2.5 Teva Recent Developments/Updates
6.3 Torrent Pharma
6.3.1 Torrent Pharma Company Information
6.3.2 Torrent Pharma Description and Business Overview
6.3.3 Torrent Pharma γ-Aminobutyric Acid Receptor Agonists Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Torrent Pharma γ-Aminobutyric Acid Receptor Agonists Product Portfolio
6.3.5 Torrent Pharma Recent Developments/Updates
6.4 Roche
6.4.1 Roche Company Information
6.4.2 Roche Description and Business Overview
6.4.3 Roche γ-Aminobutyric Acid Receptor Agonists Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Roche γ-Aminobutyric Acid Receptor Agonists Product Portfolio
6.4.5 Roche Recent Developments/Updates
6.5 Akorn
6.5.1 Akorn Company Information
6.5.2 Akorn Description and Business Overview
6.5.3 Akorn γ-Aminobutyric Acid Receptor Agonists Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Akorn γ-Aminobutyric Acid Receptor Agonists Product Portfolio
6.5.5 Akorn Recent Developments/Updates
6.6 Apotex
6.6.1 Apotex Company Information
6.6.2 Apotex Description and Business Overview
6.6.3 Apotex γ-Aminobutyric Acid Receptor Agonists Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Apotex γ-Aminobutyric Acid Receptor Agonists Product Portfolio
6.6.5 Apotex Recent Developments/Updates
6.7 Fresenius Kabi
6.7.1 Fresenius Kabi Company Information
6.7.2 Fresenius Kabi Description and Business Overview
6.7.3 Fresenius Kabi γ-Aminobutyric Acid Receptor Agonists Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Fresenius Kabi γ-Aminobutyric Acid Receptor Agonists Product Portfolio
6.7.5 Fresenius Kabi Recent Developments/Updates
6.8 Hikma
6.8.1 Hikma Company Information
6.8.2 Hikma Description and Business Overview
6.8.3 Hikma γ-Aminobutyric Acid Receptor Agonists Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Hikma γ-Aminobutyric Acid Receptor Agonists Product Portfolio
6.8.5 Hikma Recent Developments/Updates
6.9 Mylan
6.9.1 Mylan Company Information
6.9.2 Mylan Description and Business Overview
6.9.3 Mylan γ-Aminobutyric Acid Receptor Agonists Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Mylan γ-Aminobutyric Acid Receptor Agonists Product Portfolio
6.9.5 Mylan Recent Developments/Updates
6.10 Sandoz
6.10.1 Sandoz Company Information
6.10.2 Sandoz Description and Business Overview
6.10.3 Sandoz γ-Aminobutyric Acid Receptor Agonists Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Sandoz γ-Aminobutyric Acid Receptor Agonists Product Portfolio
6.10.5 Sandoz Recent Developments/Updates
6.11 Sun Pharma
6.11.1 Sun Pharma Company Information
6.11.2 Sun Pharma Description and Business Overview
6.11.3 Sun Pharma γ-Aminobutyric Acid Receptor Agonists Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Sun Pharma γ-Aminobutyric Acid Receptor Agonists Product Portfolio
6.11.5 Sun Pharma Recent Developments/Updates
6.12 WG Critical Care
6.12.1 WG Critical Care Company Information
6.12.2 WG Critical Care Description and Business Overview
6.12.3 WG Critical Care γ-Aminobutyric Acid Receptor Agonists Sales, Revenue and Gross Margin (2020-2025)
6.12.4 WG Critical Care γ-Aminobutyric Acid Receptor Agonists Product Portfolio
6.12.5 WG Critical Care Recent Developments/Updates
6.13 Takeda
6.13.1 Takeda Company Information
6.13.2 Takeda Description and Business Overview
6.13.3 Takeda γ-Aminobutyric Acid Receptor Agonists Sales, Revenue and Gross Margin (2020-2025)
6.13.4 Takeda γ-Aminobutyric Acid Receptor Agonists Product Portfolio
6.13.5 Takeda Recent Developments/Updates
6.14 Shanghai Pharmaceuticals Holding
6.14.1 Shanghai Pharmaceuticals Holding Company Information
6.14.2 Shanghai Pharmaceuticals Holding Description and Business Overview
6.14.3 Shanghai Pharmaceuticals Holding γ-Aminobutyric Acid Receptor Agonists Sales, Revenue and Gross Margin (2020-2025)
6.14.4 Shanghai Pharmaceuticals Holding γ-Aminobutyric Acid Receptor Agonists Product Portfolio
6.14.5 Shanghai Pharmaceuticals Holding Recent Developments/Updates
6.15 CHEPLAPHARM
6.15.1 CHEPLAPHARM Company Information
6.15.2 CHEPLAPHARM Description and Business Overview
6.15.3 CHEPLAPHARM γ-Aminobutyric Acid Receptor Agonists Sales, Revenue and Gross Margin (2020-2025)
6.15.4 CHEPLAPHARM γ-Aminobutyric Acid Receptor Agonists Product Portfolio
6.15.5 CHEPLAPHARM Recent Developments/Updates
6.16 Neurelis
6.16.1 Neurelis Company Information
6.16.2 Neurelis Description and Business Overview
6.16.3 Neurelis γ-Aminobutyric Acid Receptor Agonists Sales, Revenue and Gross Margin (2020-2025)
6.16.4 Neurelis γ-Aminobutyric Acid Receptor Agonists Product Portfolio
6.16.5 Neurelis Recent Developments/Updates
6.17 Huazhong Pharmaceutical
6.17.1 Huazhong Pharmaceutical Company Information
6.17.2 Huazhong Pharmaceutical Description and Business Overview
6.17.3 Huazhong Pharmaceutical γ-Aminobutyric Acid Receptor Agonists Sales, Revenue and Gross Margin (2020-2025)
6.17.4 Huazhong Pharmaceutical γ-Aminobutyric Acid Receptor Agonists Product Portfolio
6.17.5 Huazhong Pharmaceutical Recent Developments/Updates
6.18 Changzhou Siyao Pharmaceutical
6.18.1 Changzhou Siyao Pharmaceutical Company Information
6.18.2 Changzhou Siyao Pharmaceutical Description and Business Overview
6.18.3 Changzhou Siyao Pharmaceutical γ-Aminobutyric Acid Receptor Agonists Sales, Revenue and Gross Margin (2020-2025)
6.18.4 Changzhou Siyao Pharmaceutical γ-Aminobutyric Acid Receptor Agonists Product Portfolio
6.18.5 Changzhou Siyao Pharmaceutical Recent Developments/Updates
6.19 SAGE Therapeutics
6.19.1 SAGE Therapeutics Company Information
6.19.2 SAGE Therapeutics Description and Business Overview
6.19.3 SAGE Therapeutics γ-Aminobutyric Acid Receptor Agonists Sales, Revenue and Gross Margin (2020-2025)
6.19.4 SAGE Therapeutics γ-Aminobutyric Acid Receptor Agonists Product Portfolio
6.19.5 SAGE Therapeutics Recent Developments/Updates
6.20 GSK
6.20.1 GSK Company Information
6.20.2 GSK Description and Business Overview
6.20.3 GSK γ-Aminobutyric Acid Receptor Agonists Sales, Revenue and Gross Margin (2020-2025)
6.20.4 GSK γ-Aminobutyric Acid Receptor Agonists Product Portfolio
6.20.5 GSK Recent Developments/Updates
6.21 Sanofi
6.21.1 Sanofi Company Information
6.21.2 Sanofi Description and Business Overview
6.21.3 Sanofi γ-Aminobutyric Acid Receptor Agonists Sales, Revenue and Gross Margin (2020-2025)
6.21.4 Sanofi γ-Aminobutyric Acid Receptor Agonists Product Portfolio
6.21.5 Sanofi Recent Developments/Updates
6.22 Sichuan HaiscoPharmaceuical
6.22.1 Sichuan HaiscoPharmaceuical Company Information
6.22.2 Sichuan HaiscoPharmaceuical Description and Business Overview
6.22.3 Sichuan HaiscoPharmaceuical γ-Aminobutyric Acid Receptor Agonists Sales, Revenue and Gross Margin (2020-2025)
6.22.4 Sichuan HaiscoPharmaceuical γ-Aminobutyric Acid Receptor Agonists Product Portfolio
6.22.5 Sichuan HaiscoPharmaceuical Recent Developments/Updates
6.23 Novartis
6.23.1 Novartis Company Information
6.23.2 Novartis Description and Business Overview
6.23.3 Novartis γ-Aminobutyric Acid Receptor Agonists Sales, Revenue and Gross Margin (2020-2025)
6.23.4 Novartis γ-Aminobutyric Acid Receptor Agonists Product Portfolio
6.23.5 Novartis Recent Developments/Updates
6.24 AstraZeneca
6.24.1 AstraZeneca Company Information
6.24.2 AstraZeneca Description and Business Overview
6.24.3 AstraZeneca γ-Aminobutyric Acid Receptor Agonists Sales, Revenue and Gross Margin (2020-2025)
6.24.4 AstraZeneca γ-Aminobutyric Acid Receptor Agonists Product Portfolio
6.24.5 AstraZeneca Recent Developments/Updates
6.25 Viatris
6.25.1 Viatris Company Information
6.25.2 Viatris Description and Business Overview
6.25.3 Viatris γ-Aminobutyric Acid Receptor Agonists Sales, Revenue and Gross Margin (2020-2025)
6.25.4 Viatris γ-Aminobutyric Acid Receptor Agonists Product Portfolio
6.25.5 Viatris Recent Developments/Updates
6.26 Jazz Pharmaceuicals
6.26.1 Jazz Pharmaceuicals Company Information
6.26.2 Jazz Pharmaceuicals Description and Business Overview
6.26.3 Jazz Pharmaceuicals γ-Aminobutyric Acid Receptor Agonists Sales, Revenue and Gross Margin (2020-2025)
6.26.4 Jazz Pharmaceuicals γ-Aminobutyric Acid Receptor Agonists Product Portfolio
6.26.5 Jazz Pharmaceuicals Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 γ-Aminobutyric Acid Receptor Agonists Industry Chain Analysis
7.2 γ-Aminobutyric Acid Receptor Agonists Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 γ-Aminobutyric Acid Receptor Agonists Production Mode & Process Analysis
7.4 γ-Aminobutyric Acid Receptor Agonists Sales and Marketing
7.4.1 γ-Aminobutyric Acid Receptor Agonists Sales Channels
7.4.2 γ-Aminobutyric Acid Receptor Agonists Distributors
7.5 γ-Aminobutyric Acid Receptor Agonists Customer Analysis
8 γ-Aminobutyric Acid Receptor Agonists Market Dynamics
8.1 γ-Aminobutyric Acid Receptor Agonists Industry Trends
8.2 γ-Aminobutyric Acid Receptor Agonists Market Drivers
8.3 γ-Aminobutyric Acid Receptor Agonists Market Challenges
8.4 γ-Aminobutyric Acid Receptor Agonists Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global γ-Aminobutyric Acid Receptor Agonists Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global γ-Aminobutyric Acid Receptor Agonists Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global γ-Aminobutyric Acid Receptor Agonists Market Competitive Situation by Manufacturers in 2024
 Table 4. Global γ-Aminobutyric Acid Receptor Agonists Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global γ-Aminobutyric Acid Receptor Agonists Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global γ-Aminobutyric Acid Receptor Agonists Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global γ-Aminobutyric Acid Receptor Agonists Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market γ-Aminobutyric Acid Receptor Agonists Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of γ-Aminobutyric Acid Receptor Agonists, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of γ-Aminobutyric Acid Receptor Agonists, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of γ-Aminobutyric Acid Receptor Agonists, Product Type & Application
 Table 12. Global Key Manufacturers of γ-Aminobutyric Acid Receptor Agonists, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global γ-Aminobutyric Acid Receptor Agonists by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in γ-Aminobutyric Acid Receptor Agonists as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global γ-Aminobutyric Acid Receptor Agonists Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global γ-Aminobutyric Acid Receptor Agonists Sales by Region (2020-2025) & (K Units)
 Table 18. Global γ-Aminobutyric Acid Receptor Agonists Sales Market Share by Region (2020-2025)
 Table 19. Global γ-Aminobutyric Acid Receptor Agonists Sales by Region (2026-2031) & (K Units)
 Table 20. Global γ-Aminobutyric Acid Receptor Agonists Sales Market Share by Region (2026-2031)
 Table 21. Global γ-Aminobutyric Acid Receptor Agonists Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global γ-Aminobutyric Acid Receptor Agonists Revenue Market Share by Region (2020-2025)
 Table 23. Global γ-Aminobutyric Acid Receptor Agonists Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global γ-Aminobutyric Acid Receptor Agonists Revenue Market Share by Region (2026-2031)
 Table 25. North America γ-Aminobutyric Acid Receptor Agonists Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America γ-Aminobutyric Acid Receptor Agonists Sales by Country (2020-2025) & (K Units)
 Table 27. North America γ-Aminobutyric Acid Receptor Agonists Sales by Country (2026-2031) & (K Units)
 Table 28. North America γ-Aminobutyric Acid Receptor Agonists Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America γ-Aminobutyric Acid Receptor Agonists Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe γ-Aminobutyric Acid Receptor Agonists Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe γ-Aminobutyric Acid Receptor Agonists Sales by Country (2020-2025) & (K Units)
 Table 32. Europe γ-Aminobutyric Acid Receptor Agonists Sales by Country (2026-2031) & (K Units)
 Table 33. Europe γ-Aminobutyric Acid Receptor Agonists Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe γ-Aminobutyric Acid Receptor Agonists Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific γ-Aminobutyric Acid Receptor Agonists Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific γ-Aminobutyric Acid Receptor Agonists Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific γ-Aminobutyric Acid Receptor Agonists Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific γ-Aminobutyric Acid Receptor Agonists Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific γ-Aminobutyric Acid Receptor Agonists Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America γ-Aminobutyric Acid Receptor Agonists Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America γ-Aminobutyric Acid Receptor Agonists Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America γ-Aminobutyric Acid Receptor Agonists Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America γ-Aminobutyric Acid Receptor Agonists Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America γ-Aminobutyric Acid Receptor Agonists Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa γ-Aminobutyric Acid Receptor Agonists Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa γ-Aminobutyric Acid Receptor Agonists Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa γ-Aminobutyric Acid Receptor Agonists Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa γ-Aminobutyric Acid Receptor Agonists Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa γ-Aminobutyric Acid Receptor Agonists Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global γ-Aminobutyric Acid Receptor Agonists Sales (K Units) by Type (2020-2025)
 Table 51. Global γ-Aminobutyric Acid Receptor Agonists Sales (K Units) by Type (2026-2031)
 Table 52. Global γ-Aminobutyric Acid Receptor Agonists Sales Market Share by Type (2020-2025)
 Table 53. Global γ-Aminobutyric Acid Receptor Agonists Sales Market Share by Type (2026-2031)
 Table 54. Global γ-Aminobutyric Acid Receptor Agonists Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global γ-Aminobutyric Acid Receptor Agonists Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global γ-Aminobutyric Acid Receptor Agonists Revenue Market Share by Type (2020-2025)
 Table 57. Global γ-Aminobutyric Acid Receptor Agonists Revenue Market Share by Type (2026-2031)
 Table 58. Global γ-Aminobutyric Acid Receptor Agonists Price (US$/Unit) by Type (2020-2025)
 Table 59. Global γ-Aminobutyric Acid Receptor Agonists Price (US$/Unit) by Type (2026-2031)
 Table 60. Global γ-Aminobutyric Acid Receptor Agonists Sales (K Units) by Application (2020-2025)
 Table 61. Global γ-Aminobutyric Acid Receptor Agonists Sales (K Units) by Application (2026-2031)
 Table 62. Global γ-Aminobutyric Acid Receptor Agonists Sales Market Share by Application (2020-2025)
 Table 63. Global γ-Aminobutyric Acid Receptor Agonists Sales Market Share by Application (2026-2031)
 Table 64. Global γ-Aminobutyric Acid Receptor Agonists Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global γ-Aminobutyric Acid Receptor Agonists Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global γ-Aminobutyric Acid Receptor Agonists Revenue Market Share by Application (2020-2025)
 Table 67. Global γ-Aminobutyric Acid Receptor Agonists Revenue Market Share by Application (2026-2031)
 Table 68. Global γ-Aminobutyric Acid Receptor Agonists Price (US$/Unit) by Application (2020-2025)
 Table 69. Global γ-Aminobutyric Acid Receptor Agonists Price (US$/Unit) by Application (2026-2031)
 Table 70. Pfizer Company Information
 Table 71. Pfizer Description and Business Overview
 Table 72. Pfizer γ-Aminobutyric Acid Receptor Agonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. Pfizer γ-Aminobutyric Acid Receptor Agonists Product
 Table 74. Pfizer Recent Developments/Updates
 Table 75. Teva Company Information
 Table 76. Teva Description and Business Overview
 Table 77. Teva γ-Aminobutyric Acid Receptor Agonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. Teva γ-Aminobutyric Acid Receptor Agonists Product
 Table 79. Teva Recent Developments/Updates
 Table 80. Torrent Pharma Company Information
 Table 81. Torrent Pharma Description and Business Overview
 Table 82. Torrent Pharma γ-Aminobutyric Acid Receptor Agonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. Torrent Pharma γ-Aminobutyric Acid Receptor Agonists Product
 Table 84. Torrent Pharma Recent Developments/Updates
 Table 85. Roche Company Information
 Table 86. Roche Description and Business Overview
 Table 87. Roche γ-Aminobutyric Acid Receptor Agonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. Roche γ-Aminobutyric Acid Receptor Agonists Product
 Table 89. Roche Recent Developments/Updates
 Table 90. Akorn Company Information
 Table 91. Akorn Description and Business Overview
 Table 92. Akorn γ-Aminobutyric Acid Receptor Agonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 93. Akorn γ-Aminobutyric Acid Receptor Agonists Product
 Table 94. Akorn Recent Developments/Updates
 Table 95. Apotex Company Information
 Table 96. Apotex Description and Business Overview
 Table 97. Apotex γ-Aminobutyric Acid Receptor Agonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 98. Apotex γ-Aminobutyric Acid Receptor Agonists Product
 Table 99. Apotex Recent Developments/Updates
 Table 100. Fresenius Kabi Company Information
 Table 101. Fresenius Kabi Description and Business Overview
 Table 102. Fresenius Kabi γ-Aminobutyric Acid Receptor Agonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 103. Fresenius Kabi γ-Aminobutyric Acid Receptor Agonists Product
 Table 104. Fresenius Kabi Recent Developments/Updates
 Table 105. Hikma Company Information
 Table 106. Hikma Description and Business Overview
 Table 107. Hikma γ-Aminobutyric Acid Receptor Agonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 108. Hikma γ-Aminobutyric Acid Receptor Agonists Product
 Table 109. Hikma Recent Developments/Updates
 Table 110. Mylan Company Information
 Table 111. Mylan Description and Business Overview
 Table 112. Mylan γ-Aminobutyric Acid Receptor Agonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 113. Mylan γ-Aminobutyric Acid Receptor Agonists Product
 Table 114. Mylan Recent Developments/Updates
 Table 115. Sandoz Company Information
 Table 116. Sandoz Description and Business Overview
 Table 117. Sandoz γ-Aminobutyric Acid Receptor Agonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 118. Sandoz γ-Aminobutyric Acid Receptor Agonists Product
 Table 119. Sandoz Recent Developments/Updates
 Table 120. Sun Pharma Company Information
 Table 121. Sun Pharma Description and Business Overview
 Table 122. Sun Pharma γ-Aminobutyric Acid Receptor Agonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 123. Sun Pharma γ-Aminobutyric Acid Receptor Agonists Product
 Table 124. Sun Pharma Recent Developments/Updates
 Table 125. WG Critical Care Company Information
 Table 126. WG Critical Care Description and Business Overview
 Table 127. WG Critical Care γ-Aminobutyric Acid Receptor Agonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 128. WG Critical Care γ-Aminobutyric Acid Receptor Agonists Product
 Table 129. WG Critical Care Recent Developments/Updates
 Table 130. Takeda Company Information
 Table 131. Takeda Description and Business Overview
 Table 132. Takeda γ-Aminobutyric Acid Receptor Agonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 133. Takeda γ-Aminobutyric Acid Receptor Agonists Product
 Table 134. Takeda Recent Developments/Updates
 Table 135. Shanghai Pharmaceuticals Holding Company Information
 Table 136. Shanghai Pharmaceuticals Holding Description and Business Overview
 Table 137. Shanghai Pharmaceuticals Holding γ-Aminobutyric Acid Receptor Agonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 138. Shanghai Pharmaceuticals Holding γ-Aminobutyric Acid Receptor Agonists Product
 Table 139. Shanghai Pharmaceuticals Holding Recent Developments/Updates
 Table 140. CHEPLAPHARM Company Information
 Table 141. CHEPLAPHARM Description and Business Overview
 Table 142. CHEPLAPHARM γ-Aminobutyric Acid Receptor Agonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 143. CHEPLAPHARM γ-Aminobutyric Acid Receptor Agonists Product
 Table 144. CHEPLAPHARM Recent Developments/Updates
 Table 145. Neurelis Company Information
 Table 146. Neurelis Description and Business Overview
 Table 147. Neurelis γ-Aminobutyric Acid Receptor Agonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 148. Neurelis γ-Aminobutyric Acid Receptor Agonists Product
 Table 149. Neurelis Recent Developments/Updates
 Table 150. Huazhong Pharmaceutical Company Information
 Table 151. Huazhong Pharmaceutical Description and Business Overview
 Table 152. Huazhong Pharmaceutical γ-Aminobutyric Acid Receptor Agonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 153. Huazhong Pharmaceutical γ-Aminobutyric Acid Receptor Agonists Product
 Table 154. Huazhong Pharmaceutical Recent Developments/Updates
 Table 155. Changzhou Siyao Pharmaceutical Company Information
 Table 156. Changzhou Siyao Pharmaceutical Description and Business Overview
 Table 157. Changzhou Siyao Pharmaceutical γ-Aminobutyric Acid Receptor Agonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 158. Changzhou Siyao Pharmaceutical γ-Aminobutyric Acid Receptor Agonists Product
 Table 159. Changzhou Siyao Pharmaceutical Recent Developments/Updates
 Table 160. SAGE Therapeutics Company Information
 Table 161. SAGE Therapeutics Description and Business Overview
 Table 162. SAGE Therapeutics γ-Aminobutyric Acid Receptor Agonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 163. SAGE Therapeutics γ-Aminobutyric Acid Receptor Agonists Product
 Table 164. SAGE Therapeutics Recent Developments/Updates
 Table 165. GSK Company Information
 Table 166. GSK Description and Business Overview
 Table 167. GSK γ-Aminobutyric Acid Receptor Agonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 168. GSK γ-Aminobutyric Acid Receptor Agonists Product
 Table 169. GSK Recent Developments/Updates
 Table 170. Sanofi Company Information
 Table 171. Sanofi Description and Business Overview
 Table 172. Sanofi γ-Aminobutyric Acid Receptor Agonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 173. Sanofi γ-Aminobutyric Acid Receptor Agonists Product
 Table 174. Sanofi Recent Developments/Updates
 Table 175. Sichuan HaiscoPharmaceuical Company Information
 Table 176. Sichuan HaiscoPharmaceuical Description and Business Overview
 Table 177. Sichuan HaiscoPharmaceuical γ-Aminobutyric Acid Receptor Agonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 178. Sichuan HaiscoPharmaceuical γ-Aminobutyric Acid Receptor Agonists Product
 Table 179. Sichuan HaiscoPharmaceuical Recent Developments/Updates
 Table 180. Novartis Company Information
 Table 181. Novartis Description and Business Overview
 Table 182. Novartis γ-Aminobutyric Acid Receptor Agonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 183. Novartis γ-Aminobutyric Acid Receptor Agonists Product
 Table 184. Novartis Recent Developments/Updates
 Table 185. AstraZeneca Company Information
 Table 186. AstraZeneca Description and Business Overview
 Table 187. AstraZeneca γ-Aminobutyric Acid Receptor Agonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 188. AstraZeneca γ-Aminobutyric Acid Receptor Agonists Product
 Table 189. AstraZeneca Recent Developments/Updates
 Table 190. Viatris Company Information
 Table 191. Viatris Description and Business Overview
 Table 192. Viatris γ-Aminobutyric Acid Receptor Agonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 193. Viatris γ-Aminobutyric Acid Receptor Agonists Product
 Table 194. Viatris Recent Developments/Updates
 Table 195. Jazz Pharmaceuicals Company Information
 Table 196. Jazz Pharmaceuicals Description and Business Overview
 Table 197. Jazz Pharmaceuicals γ-Aminobutyric Acid Receptor Agonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 198. Jazz Pharmaceuicals γ-Aminobutyric Acid Receptor Agonists Product
 Table 199. Jazz Pharmaceuicals Recent Developments/Updates
 Table 200. Key Raw Materials Lists
 Table 201. Raw Materials Key Suppliers Lists
 Table 202. γ-Aminobutyric Acid Receptor Agonists Distributors List
 Table 203. γ-Aminobutyric Acid Receptor Agonists Customers List
 Table 204. γ-Aminobutyric Acid Receptor Agonists Market Trends
 Table 205. γ-Aminobutyric Acid Receptor Agonists Market Drivers
 Table 206. γ-Aminobutyric Acid Receptor Agonists Market Challenges
 Table 207. γ-Aminobutyric Acid Receptor Agonists Market Restraints
 Table 208. Research Programs/Design for This Report
 Table 209. Key Data Information from Secondary Sources
 Table 210. Key Data Information from Primary Sources
 Table 211. Authors List of This Report


List of Figures
 Figure 1. Product Picture of γ-Aminobutyric Acid Receptor Agonists
 Figure 2. Global γ-Aminobutyric Acid Receptor Agonists Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global γ-Aminobutyric Acid Receptor Agonists Market Share by Type: 2024 & 2031
 Figure 4. GABAA Receptors Product Picture
 Figure 5. GABAB Receptors Product Picture
 Figure 6. GABAC Receptors Product Picture
 Figure 7. Global γ-Aminobutyric Acid Receptor Agonists Market Value by Application (2020-2031) & (US$ Million)
 Figure 8. Global γ-Aminobutyric Acid Receptor Agonists Market Share by Application: 2024 & 2031
 Figure 9. Epilepsy
 Figure 10. Insomnia
 Figure 11. Anxiety
 Figure 12. Neuropathic Pain
 Figure 13. Other
 Figure 14. Global γ-Aminobutyric Acid Receptor Agonists Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 15. Global γ-Aminobutyric Acid Receptor Agonists Market Size (2020-2031) & (US$ Million)
 Figure 16. Global γ-Aminobutyric Acid Receptor Agonists Sales (2020-2031) & (K Units)
 Figure 17. Global γ-Aminobutyric Acid Receptor Agonists Average Price (US$/Unit) & (2020-2031)
 Figure 18. γ-Aminobutyric Acid Receptor Agonists Report Years Considered
 Figure 19. γ-Aminobutyric Acid Receptor Agonists Sales Share by Manufacturers in 2024
 Figure 20. Global γ-Aminobutyric Acid Receptor Agonists Revenue Share by Manufacturers in 2024
 Figure 21. Global 5 and 10 Largest γ-Aminobutyric Acid Receptor Agonists Players: Market Share by Revenue in γ-Aminobutyric Acid Receptor Agonists in 2024
 Figure 22. γ-Aminobutyric Acid Receptor Agonists Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 23. Global γ-Aminobutyric Acid Receptor Agonists Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 24. North America γ-Aminobutyric Acid Receptor Agonists Sales Market Share by Country (2020-2031)
 Figure 25. North America γ-Aminobutyric Acid Receptor Agonists Revenue Market Share by Country (2020-2031)
 Figure 26. United States γ-Aminobutyric Acid Receptor Agonists Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 27. Canada γ-Aminobutyric Acid Receptor Agonists Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. Europe γ-Aminobutyric Acid Receptor Agonists Sales Market Share by Country (2020-2031)
 Figure 29. Europe γ-Aminobutyric Acid Receptor Agonists Revenue Market Share by Country (2020-2031)
 Figure 30. Germany γ-Aminobutyric Acid Receptor Agonists Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. France γ-Aminobutyric Acid Receptor Agonists Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. U.K. γ-Aminobutyric Acid Receptor Agonists Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 33. Italy γ-Aminobutyric Acid Receptor Agonists Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 34. Russia γ-Aminobutyric Acid Receptor Agonists Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. Asia Pacific γ-Aminobutyric Acid Receptor Agonists Sales Market Share by Region (2020-2031)
 Figure 36. Asia Pacific γ-Aminobutyric Acid Receptor Agonists Revenue Market Share by Region (2020-2031)
 Figure 37. China γ-Aminobutyric Acid Receptor Agonists Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. Japan γ-Aminobutyric Acid Receptor Agonists Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. South Korea γ-Aminobutyric Acid Receptor Agonists Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. India γ-Aminobutyric Acid Receptor Agonists Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Australia γ-Aminobutyric Acid Receptor Agonists Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. China Taiwan γ-Aminobutyric Acid Receptor Agonists Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Southeast Asia γ-Aminobutyric Acid Receptor Agonists Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Latin America γ-Aminobutyric Acid Receptor Agonists Sales Market Share by Country (2020-2031)
 Figure 45. Latin America γ-Aminobutyric Acid Receptor Agonists Revenue Market Share by Country (2020-2031)
 Figure 46. Mexico γ-Aminobutyric Acid Receptor Agonists Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Brazil γ-Aminobutyric Acid Receptor Agonists Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Argentina γ-Aminobutyric Acid Receptor Agonists Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Colombia γ-Aminobutyric Acid Receptor Agonists Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. Middle East and Africa γ-Aminobutyric Acid Receptor Agonists Sales Market Share by Country (2020-2031)
 Figure 51. Middle East and Africa γ-Aminobutyric Acid Receptor Agonists Revenue Market Share by Country (2020-2031)
 Figure 52. Turkey γ-Aminobutyric Acid Receptor Agonists Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 53. Saudi Arabia γ-Aminobutyric Acid Receptor Agonists Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 54. UAE γ-Aminobutyric Acid Receptor Agonists Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 55. Global Sales Market Share of γ-Aminobutyric Acid Receptor Agonists by Type (2020-2031)
 Figure 56. Global Revenue Market Share of γ-Aminobutyric Acid Receptor Agonists by Type (2020-2031)
 Figure 57. Global γ-Aminobutyric Acid Receptor Agonists Price (US$/Unit) by Type (2020-2031)
 Figure 58. Global Sales Market Share of γ-Aminobutyric Acid Receptor Agonists by Application (2020-2031)
 Figure 59. Global Revenue Market Share of γ-Aminobutyric Acid Receptor Agonists by Application (2020-2031)
 Figure 60. Global γ-Aminobutyric Acid Receptor Agonists Price (US$/Unit) by Application (2020-2031)
 Figure 61. γ-Aminobutyric Acid Receptor Agonists Value Chain
 Figure 62. Channels of Distribution (Direct Vs Distribution)
 Figure 63. Bottom-up and Top-down Approaches for This Report
 Figure 64. Data Triangulation
 Figure 65. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Nano Dimension